Medlab Clinical is a medical research and development facility researching and formulating novel bio-therapeutics (e.g., nutraceuticals and pharmaceuticals) to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease and pre-diabetes/obesity.
WKN: A14R7W / ISIN: AU000000MDC8 Kürzel: ASX:MDC in D. handelbar:
Gründungsjahr: Heimatbörse: ASX Vollzogene Namenswechsel: Land: Angestellte: